Vycor Medical (VYCO) Divestments (2019 - 2020)

Vycor Medical's (VYCO) quarterly Divestments came in at $9950.0 in Q3 2020, up 98.01% year-on-year from $5025.0 in Q4 2019, and up 911.58% on a QoQ basis from -$1226.0 in Q2 2020.

Vycor Medical (VYCO) Divestments (2019 - 2020) Analysis & Trends

Vycor Medical (VYCO) has 2 years of Divestments data on file, last reported at $9950.0 in Q3 2020.

  • On a quarterly basis, Divestments rose 98.01% year-over-year to $9950.0 in Q3 2020; TTM through Dec 2020 was $9574.0, a N/A change from a year earlier, with the FY2020 full-year figure at $9574.0, up 289.82% from the prior year.
  • Divestments for Q3 2020 stood at $9950.0, up from -$1226.0 in the prior quarter.
  • Over the last five years, Divestments for VYCO reached as high as $9950.0 in Q3 2020 and fell as low as -$1226.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.37 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Vycor Medical 2.34 Mn 2.16 Mn 375,153.00 -

Historic Data

Download Data
DateValue
Sep 30, 2020 9,950.00
Jun 30, 2020 -1,226.00
Mar 31, 2020 850.00
Dec 31, 2019 -40.00
Sep 30, 2019 5,025.00